-
11.08.2024 Consolidated Financial Results for the Second Quarter of Fiscal Year 2024
（309KB）
読む Consolidated Financial Results for the Second Quarter of Fiscal Year 2024
-
10.16.2024 Seikagaku Announces Regulatory Approval in China for MucoUp, a Submucosal Injection Agent for Endoscopic Surgery, and Conclusion of a Distribution Agreement with Tozai Boeki Kaisha, Ltd.
（140KB）
-
08.05.2024 Consolidated Financial Results for the First Quarter of Fiscal 2024
（292KB）
読む Consolidated Financial Results for the First Quarter of Fiscal 2024
-
05.23.2024 Convocation Notice of the 78th Ordinary General Meeting of Shareholders
（174KB）
読む Convocation Notice of the 78th Ordinary General Meeting of Shareholders
Seikagaku News Releases are issued to provide stakeholders with the most up-to-date information related to our company.
-
01.24.2025 Seikagaku will announce the financial results for the Third Quarter of the Fiscal Year ending March 31, 2025 at 16:00 on February 7, 2025
-
11.13.2024 Presentation Material for the Briefing on the Second Quarter FY2024 Financial Results
読む Presentation Material for the Briefing on the Second Quarter FY2024 Financial Results
-
11.08.2024 Seikagaku announced the financial results for the Second Quarter of the Fiscal Year ending March 31, 2025
-
10.25.2024 Seikagaku will announcement of The Second Quarter of FY2024 Financial Results, 2024 at 16:00 on November 8
